Exact Mass: 476.2635
Exact Mass Matches: 476.2635
Found 500 metabolites which its exact mass value is equals to given mass value 476.2635
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cyclic-3,20-bis(1,2-ethanediyl acetal)-11alpha-(acetyloxy)-5alpha,6alpha-epoxypregnane-3,20-dione
Lucidenic acid G
Lucidenic acid G is found in mushrooms. Lucidenic acid G is a metabolite of Ganoderma lucidum (reishi Metabolite of Ganoderma lucidum (reishi). Lucidenic acid G is found in mushrooms.
Lucidenic acid C
Lucidenic acid C is found in mushrooms. Lucidenic acid C is a metabolite of Ganoderma lucidum (reishi). Metabolite of Ganoderma lucidum (reishi). Lucidenic acid C is found in mushrooms.
Lucidenic acid H
Isolated from Citrus paradisi (grapefruit), Thea sinensis (tea) and many other sources. Flavouring ingredient Lucidenic acid H is found in mushrooms. Lucidenic acid H is a constituent of Ganoderma lucidum (reishi)
Betamethasone 17 Valerate
DG(2:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
DG(2:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/2:0/0:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
DG(2:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/2:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)
DG(2:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/2:0/0:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
DG(2:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/2:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
LucidenicacidC
Lucidenic acid C is a triterpenoid. lucidenic acid C is a natural product found in Ganoderma lucidum with data available. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Calofloride
Mulberrofuran Z
Sophoraisoflavanone C
2-[2,3-Dihydro-2-(1-hydroxy-1-methylethyl)-7-(3-methyl-2-butenyl)-5-benzofuranyl]-2,3-dihydro-7-hydroxy-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
3,7,15,28-Tetrahydroxy-25,26,27-trinor-11-oxolanosta-8,20-dien-24-oic acid
Betamethasone 17-valerate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids CONFIDENCE standard compound; INTERNAL_ID 2833 D000893 - Anti-Inflammatory Agents
-4-Chloro-3-hydroxy-23-oxoergost-24(28)-en-21-oic acid
3beta,6beta-bis(3-methylpentanoyloxy)furanoeremophilan-15-oic acid
7-hydroxy-2-[3-hydroxy-2,2-dimethyl-8-(3-methylbut-2-enyl)-3,4-dihydrochromen-6-yl]-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
3,4-dehydro-4-dehydroxypodachaenin|3-costoyloxydehydroleucodin
lespeflorin B3
A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 3, 7 and 4 and prenyl groups at positions 6, 8 and 3. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
caseabalansin C|rel-(2R,5R,6R,8S,9S,10R,18R,19R)-2,19-diacetoxy-18-ethoxy-6-methoxycleroda-3,13(16),14-trien-18,19-oxolane
Tri-Ac-(3beta,5alpha,17alphaOH)-3,17,21-Trihydroxypregnan-20-one
caseargrewiin G|rel-(2R,5S,6S,8R,9R,10S,18S,19S)-18-methoxy-19-acetoxy-18,19-epoxy-2-butanoyloxy-6-hydroxycleroda-3,12(Z),14-triene
1-Hydroxy-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoethanolamine
1-(9Z,12Z-Octadecadienoyl)-2-hydroxy-sn-glycero-3-phosphoethanolamine
Betamethasone valerate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9654; ORIGINAL_PRECURSOR_SCAN_NO 9651 CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9695; ORIGINAL_PRECURSOR_SCAN_NO 9693 CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9706; ORIGINAL_PRECURSOR_SCAN_NO 9701 CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9748; ORIGINAL_PRECURSOR_SCAN_NO 9744 CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9758; ORIGINAL_PRECURSOR_SCAN_NO 9757 CONFIDENCE standard compound; INTERNAL_ID 667; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9768; ORIGINAL_PRECURSOR_SCAN_NO 9765
Ala Cys Lys Arg
Ala Cys Arg Lys
Ala His His Ile
Ala His His Leu
Ala His Ile His
Ala His Leu His
Ala Ile His His
Ala Lys Cys Arg
Ala Lys Lys Met
Ala Lys Met Lys
Ala Lys Arg Cys
Ala Leu His His
Ala Met Lys Lys
Ala Arg Cys Lys
Ala Arg Lys Cys
Cys Ala Lys Arg
Cys Ala Arg Lys
Cys Lys Ala Arg
Cys Lys Lys Val
Cys Lys Arg Ala
Cys Lys Val Lys
Cys Arg Ala Lys
Cys Arg Lys Ala
Cys Val Lys Lys
Asp Lys Lys Ser
Asp Lys Ser Lys
Asp Ser Lys Lys
Phe Ile Pro Thr
Phe Ile Thr Pro
Phe Leu Pro Thr
Phe Leu Thr Pro
Phe Pro Ile Thr
Phe Pro Leu Thr
Phe Pro Thr Ile
Phe Pro Thr Leu
Phe Thr Ile Pro
Phe Thr Leu Pro
Phe Thr Pro Ile
Phe Thr Pro Leu
His Ala His Ile
His Ala His Leu
His Ala Ile His
His Ala Leu His
His His Ala Ile
His His Ala Leu
His His Ile Ala
His His Leu Ala
His Ile Ala His
His Ile His Ala
His Leu Ala His
His Leu His Ala
Ile Ala His His
Ile Phe Pro Thr
Ile Phe Thr Pro
Ile His Ala His
Ile His His Ala
Ile Ile Met Thr
Ile Ile Thr Met
Ile Leu Met Thr
Ile Leu Thr Met
Ile Met Ile Thr
Ile Met Leu Thr
Ile Met Thr Ile
Ile Met Thr Leu
Ile Pro Phe Thr
Ile Pro Thr Phe
Ile Thr Phe Pro
Ile Thr Ile Met
Ile Thr Leu Met
Ile Thr Met Ile
Ile Thr Met Leu
Ile Thr Pro Phe
Lys Ala Cys Arg
Lys Ala Lys Met
Lys Ala Met Lys
Lys Ala Arg Cys
Lys Cys Ala Arg
Lys Cys Lys Val
Lys Cys Arg Ala
Lys Cys Val Lys
Lys Asp Lys Ser
Lys Asp Ser Lys
Lys Lys Ala Met
Lys Lys Cys Val
Lys Lys Asp Ser
Lys Lys Met Ala
Lys Lys Ser Asp
Lys Lys Val Cys
Lys Met Ala Lys
Lys Met Lys Ala
Lys Gln Thr Thr
Lys Arg Ala Cys
Lys Arg Cys Ala
Lys Arg Ser Ser
Lys Ser Asp Lys
Lys Ser Lys Asp
Lys Ser Arg Ser
Lys Ser Ser Arg
Lys Thr Gln Thr
Lys Thr Thr Gln
Lys Val Cys Lys
Lys Val Lys Cys
Leu Ala His His
Leu Phe Pro Thr
Leu Phe Thr Pro
Leu His Ala His
Leu His His Ala
Leu Ile Met Thr
Leu Ile Thr Met
Leu Leu Met Thr
Leu Leu Thr Met
Leu Met Ile Thr
Leu Met Leu Thr
Leu Met Thr Ile
Leu Met Thr Leu
Leu Pro Phe Thr
Leu Pro Thr Phe
Leu Thr Phe Pro
Leu Thr Ile Met
Leu Thr Leu Met
Leu Thr Met Ile
Leu Thr Met Leu
Leu Thr Pro Phe
Met Ala Lys Lys
Met Ile Ile Thr
Met Ile Leu Thr
Met Ile Thr Ile
Met Ile Thr Leu
Met Lys Ala Lys
Met Lys Lys Ala
Met Leu Ile Thr
Met Leu Leu Thr
Met Leu Thr Ile
Met Leu Thr Leu
Met Thr Ile Ile
Met Thr Ile Leu
Met Thr Leu Ile
Met Thr Leu Leu
Pro Phe Ile Thr
Pro Phe Leu Thr
Pro Phe Thr Ile
Pro Phe Thr Leu
Pro Ile Phe Thr
Pro Ile Thr Phe
Pro Leu Phe Thr
Pro Leu Thr Phe
Pro Thr Phe Ile
Pro Thr Phe Leu
Pro Thr Ile Phe
Pro Thr Leu Phe
Pro Val Val Tyr
Pro Val Tyr Val
Pro Tyr Val Val
Gln Lys Thr Thr
Gln Thr Lys Thr
Gln Thr Thr Lys
Arg Ala Cys Lys
Arg Ala Lys Cys
Arg Cys Ala Lys
Arg Cys Lys Ala
Arg Lys Ala Cys
Arg Lys Cys Ala
Arg Lys Ser Ser
Arg Ser Lys Ser
Arg Ser Ser Lys
Ser Asp Lys Lys
Ser Lys Asp Lys
Ser Lys Lys Asp
Ser Lys Arg Ser
Ser Lys Ser Arg
Ser Arg Lys Ser
Ser Arg Ser Lys
Ser Ser Lys Arg
Ser Ser Arg Lys
Thr Phe Ile Pro
Thr Phe Leu Pro
Thr Phe Pro Ile
Thr Phe Pro Leu
Thr Ile Phe Pro
Thr Ile Ile Met
Thr Ile Leu Met
Thr Ile Met Ile
Thr Ile Met Leu
Thr Ile Pro Phe
Thr Lys Gln Thr
Thr Lys Thr Gln
Thr Leu Phe Pro
Thr Leu Ile Met
Thr Leu Leu Met
Thr Leu Met Ile
Thr Leu Met Leu
Thr Leu Pro Phe
Thr Met Ile Ile
Thr Met Ile Leu
Thr Met Leu Ile
Thr Met Leu Leu
Thr Pro Phe Ile
Thr Pro Phe Leu
Thr Pro Ile Phe
Thr Pro Leu Phe
Thr Gln Lys Thr
Thr Gln Thr Lys
Thr Thr Lys Gln
Thr Thr Gln Lys
Val Cys Lys Lys
Val Lys Cys Lys
Val Lys Lys Cys
Val Pro Val Tyr
Val Pro Tyr Val
Val Val Pro Tyr
Val Val Tyr Pro
Val Tyr Pro Val
Val Tyr Val Pro
Tyr Pro Val Val
Tyr Val Pro Val
Tyr Val Val Pro
Lucidenic acid G
Lucidenic acid H
Lucidenic acid C
(2S)-2-[bis(carboxymethyl)amino]-6-(12-sulfanyldodecanoylamino)hexanoic acid
4-Morpholinepropanoic acid,oxybis(2,1-ethanediyloxy-2,1-ethanediyl)ester
butyl 2-methylprop-2-enoate,2-hydroxyethyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate,styrene
butyl 2-methylprop-2-enoate,2-hydroxypropyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid,styrene
6-[(4-{2-[4-(2-Methyl-2-propanyl)phenyl]-1H-benzimidazol-4-yl}-1- piperazinyl)methyl]quinoxaline
DG(2:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0)
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/2:0/0:0)
DG(2:0/0:0/22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S))
DG(22:6(5Z,8E,10Z,13Z,15E,19Z)-2OH(7S, 17S)/0:0/2:0)
DG(2:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0)
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/2:0/0:0)
DG(2:0/0:0/22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17))
DG(22:6(4Z,7Z,11E,13Z,15E,19Z)-2OH(10S,17)/0:0/2:0)
schizolaenone A
A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 5, 7 and 4, a geranyl group at position 3 and a prenyl group at position 6. Isolated from Schizolaena hystrix, it exhibits cytotoxicity against ovarian cancer cell line.
3beta-(beta-D-Glucopyranosyloxy)pregna-5,16-diene-20-one
3-[[[1-[1-(2-furanylmethyl)-5-tetrazolyl]-2-methylpropyl]-(2-oxolanylmethyl)amino]methyl]-8-methyl-1H-quinolin-2-one
3-(2-fluorophenyl)-1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(2-fluorophenyl)-1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(2-fluorophenyl)-1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(2-fluorophenyl)-1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(2-fluorophenyl)-1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(2-fluorophenyl)-1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(2-fluorophenyl)-1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
(2S,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(2-pyridin-4-ylethynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
3-(2-fluorophenyl)-1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
(2R,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(2-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(2-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
3-(2-fluorophenyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(2-fluorophenyl)-1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
(2R,3R)-2-[[cyclopentylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-[2-(2-pyridinyl)ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
3-(2-fluorophenyl)-1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
(2R)-2-[(4R,5S)-8-(3-cyclopentylprop-1-ynyl)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(1S,9R,10R,11R)-10-(hydroxymethyl)-N-[2-(1-methylimidazol-4-yl)ethyl]-6-oxo-12-propyl-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
3-(2-fluorophenyl)-1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(2-fluorophenyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(2-fluorophenyl)-1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(3-fluorophenyl)-1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
(2S)-2-[(4S,5S)-8-(3-cyclopentylprop-1-ynyl)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-(3-cyclopentylprop-1-ynyl)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-8-(3-cyclopentylprop-1-ynyl)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-(3-cyclopentylprop-1-ynyl)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5S)-8-(3-cyclopentylprop-1-ynyl)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-8-(3-cyclopentylprop-1-ynyl)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-8-(3-cyclopentylprop-1-ynyl)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-8-(1-cyclopentenyl)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(1R,9S,10S,11S)-10-(hydroxymethyl)-N-[2-(1-methylimidazol-4-yl)ethyl]-6-oxo-12-propyl-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-(9Z,12Z-Octadecadienoyl)-2-hydroxy-sn-glycero-3-phosphoethanolamine
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate
1-Hydroxy-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoethanolamine
lysophosphatidylethanolamine zwitterion 18:2
A lysophosphatidylethanolamine zwitterion in which the remaining acyl group (position not specified) contains 18 carbons and 2 double bonds.
16,17-didehydropregnenolone 3-beta-D-glucoside
A sterol 3beta-D-glucoside in which the parent sterol is 16,17-didehydropregnenolone.